Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.17
Delayed Data
As of Jul 29
 +0.13 / +1.62%
Today’s Change
4.15
Today|||52-Week Range
10.74
-4.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$105.6M

Company Description

Oramed Pharmaceuticals, Inc. engages in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/4
Jerusalem Jerusalem 91390
P:(722) 566-0001
Investor Relations:

Employees

Shareholders

Individual stakeholders22.01%
Other institutional1.38%
Mutual fund holders0.11%

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Yifat ZommerChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector, Chief Medical & Scientific Officer
Roy EldorChief Medical Director